Comparing Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders: Study Protocol for a Randomized Controlled Pilot Trial

Overview

Journal Trials

Publisher Biomed Central

Specialties General Medicine
Pharmacology

Date 2016 Apr 1

PMID 27029546

Citations 2

Authors

Christina Hunger

Rebecca Hilzinger

Theresa Koch

Johannes Mander

Anja Sander

Hinrich Bents

Jochen Schweitzer

Affiliations

Soon will be listed here.

Abstract

Background: Social anxiety disorders are among the most prevalent anxiety disorders in the general population. The efficacy of cognitive behavioral therapy (CBT) for social anxiety disorders is well demonstrated. However, only three studies point to the efficacy of systemic therapy (ST) in anxiety disorders, and only two of them especially focus on social anxiety disorders. These ST studies either do not use a good comparator but minimal supportive therapy, they do not use a multi-person ST but a combined therapy, or they do not especially focus on social anxiety disorders but mood and anxiety disorders in general. Though ST was approved as evidence based in Germany for a variety of disorders in 2008, evidence did not include anxiety disorders. This is the first pilot study that will investigate multi-person ST, integrating a broad range of systemic methods, specifically for social anxiety disorders and that will compare ST to the "gold standard" CBT.

Design: This article describes the rationale and protocol of a prospective, open, interventive, balanced, bi-centric, pilot randomized controlled trial (RCT). A total of 32 patients with a primary SCID diagnosis of social anxiety disorder will be randomized to either CBT or ST. Both treatments will be manualized. The primary outcome will include social anxiety symptoms at the end of therapy. Therapy will be restricted to no more than 26 hours (primary endpoint). Secondary outcomes will include psychological, social systems and interpersonal functioning, symptom adjustment, and caregiver burden, in addition to change measures, therapist variables and treatment adherence. At the secondary endpoints, 9 and 12 months after the beginning of therapy, we will again assess all outcomes.

Discussion: The study is expected to pilot test a RCT which will be the first to directly compare CBT and multi-person ST, integrating a broad range of systemic methods, for social anxiety disorders, and it will provide empirical evidence for the calculation of the number of patients needed for a confirmatory RCT.

Trial Registration: ClinicalTrials.gov: NCT02360033 ; date of registration: 21 January 2015.

Citing Articles

Integrative systemic and family therapy for social anxiety disorder: Manual and practice in a pilot randomized controlled trial (SOPHO-CBT/ST).

Hunger-Schoppe C, Schweitzer J, Hilzinger R, Krempel L, Deusser L, Sander A Front Psychol. 2022; 13:867246.

PMID: 36405178 PMC: 9674087. DOI: 10.3389/fpsyg.2022.867246.

When Significant Others Suffer: German Validation of the Burden Assessment Scale (BAS).

Hunger C, Krause L, Hilzinger R, Ditzen B, Schweitzer J PLoS One. 2016; 11(10):e0163101.

PMID: 27764109 PMC: 5072682. DOI: 10.1371/journal.pone.0163101.

References

Aas I . Global Assessment of Functioning (GAF): properties and frontier of current knowledge. Ann Gen Psychiatry. 2010; 9:20. PMC: 2880316. DOI: 10.1186/1744-859X-9-20. View

Acarturk C, Cuijpers P, van Straten A, de Graaf R . Psychological treatment of social anxiety disorder: a meta-analysis. Psychol Med. 2008; 39(2):241-54. DOI: 10.1017/S0033291708003590. View

Mander J . The individual therapy process questionnaire: development and validation of a revised measure to evaluate general change mechanisms in psychotherapy. Clin Psychol Psychother. 2014; 22(4):328-45. DOI: 10.1002/cpp.1892. View

Arain M, Campbell M, Cooper C, Lancaster G . What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010; 10:67. PMC: 2912920. DOI: 10.1186/1471-2288-10-67. View

Alden L, Taylor C . Interpersonal processes in social phobia. Clin Psychol Rev. 2004; 24(7):857-82. DOI: 10.1016/j.cpr.2004.07.006. View

Hunger C, Krause L, Hilzinger R, Ditzen B, Schweitzer J . When Significant Others Suffer: German Validation of the Burden Assessment Scale (BAS). PLoS One. 2016; 11(10):e0163101. PMC: 5072682. DOI: 10.1371/journal.pone.0163101. View

. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013; 310(20):2191-4. DOI: 10.1001/jama.2013.281053. View

Endicott J, Spitzer R, Fleiss J, Cohen J . The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976; 33(6):766-71. DOI: 10.1001/archpsyc.1976.01770060086012. View

Taylor C, Alden L . To see ourselves as others see us: an experimental integration of the intra and interpersonal consequences of self-protection in social anxiety disorder. J Abnorm Psychol. 2011; 120(1):129-41. DOI: 10.1037/a0022127. View

10.

Mattick R, Clarke J . Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998; 36(4):455-70. DOI: 10.1016/s0005-7967(97)10031-6. View

11.

Leichsenring F, Salzer S, Beutel M, Herpertz S, Hiller W, Hoyer J . Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial. Am J Psychiatry. 2013; 170(7):759-67. DOI: 10.1176/appi.ajp.2013.12081125. View

12.

Nissen-Lie H, Monsen J, Ronnestad M . Therapist predictors of early patient-rated working alliance: a multilevel approach. Psychother Res. 2010; 20(6):627-46. DOI: 10.1080/10503307.2010.497633. View

13.

Mander J, Wittorf A, Teufel M, Schlarb A, Hautzinger M, Zipfel S . Patients with depression, somatoform disorders, and eating disorders on the stages of change: validation of a short version of the URICA. Psychotherapy (Chic). 2012; 49(4):519-27. DOI: 10.1037/a0029563. View

14.

Keller M . The lifelong course of social anxiety disorder: a clinical perspective. Acta Psychiatr Scand Suppl. 2003; (417):85-94. DOI: 10.1034/j.1600-0447.108.s417.6.x. View

15.

Zwarenstein M, Treweek S, Gagnier J, Altman D, Tunis S, Haynes B . Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008; 337:a2390. PMC: 3266844. DOI: 10.1136/bmj.a2390. View

16.

Forand N, Evans S, Haglin D, Fishman B . Cognitive behavioral therapy in practice: treatment delivered by trainees at an outpatient clinic is clinically effective. Behav Ther. 2011; 42(4):612-23. DOI: 10.1016/j.beth.2011.02.001. View

17.

Leichsenring F, Leibing E . Psychodynamic psychotherapy: a systematic review of techniques, indications and empirical evidence. Psychol Psychother. 2007; 80(Pt 2):217-28. DOI: 10.1348/147608306X117394. View

18.

Heimberg R, Liebowitz M, Hope D, Schneier F, HOLT C, Welkowitz L . Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry. 1998; 55(12):1133-41. DOI: 10.1001/archpsyc.55.12.1133. View

19.

Nissen-Lie H, Monsen J, Ulleberg P, Ronnestad M . Psychotherapists' self-reports of their interpersonal functioning and difficulties in practice as predictors of patient outcome. Psychother Res. 2012; 23(1):86-104. DOI: 10.1080/10503307.2012.735775. View

20.

Leichsenring F, Hoyer J, Beutel M, Herpertz S, Hiller W, Irle E . The social phobia psychotherapy research network. The first multicenter randomized controlled trial of psychotherapy for social phobia: rationale, methods and patient characteristics. Psychother Psychosom. 2008; 78(1):35-41. DOI: 10.1159/000162299. View